Investigating Bacopa monnieri L. Therapeutic Potential for the Treatment of Neurological Diseases


如何引用文章

全文:

详细

The popular perennial creeping plant known as Bacopa monnieri(also known as Brahmi) is being utilized in the Indian Ayurvedic medicine practice. It has a variety of bioactive phytoconstituents that have been used therapeutically to treat a number of serious illnesses. Ancient Vedic scholars used this herb because of its pharmacological effects, particularly as a nerve booster and nootropic supporter. However, it is vital to comprehend the active phytochemical components of Bacopa monnieri extract (BME) and their molecular mechanisms in order to better grasp the effect of BME on neurological illnesses and diseases. Understanding its active phytochemical constituents and their molecular processes is essential. Numerous clinical investigations indicated that BME may have neuroprotective benefits, so it is worthwhile to re-evaluate this well known plant. Here, we focused on neurological problems as we examined the pharmacological and phytochemical characteristics of BME. For their effective usage in neuroprotection and cognition, many clinical concerns and the synergistic potential of Bacopa extract have been investigated. Alzheimer’s disease is a neurological condition caused by the production of reactive oxygen species, which also causes amyloid-beta (Aβ) and tau protein aggregation and increases neuro-inflammation and neurotoxicity. Our review offers a more indepth molecular understanding of the neuroprotective functions of BME, which can also be connected to its therapeutic management of neurological illnesses and cognitive-improving effects.

作者简介

Pratima Srivastava

Department of Biotechnology, Arka Jain University

编辑信件的主要联系方式.
Email: info@benthamscience.net

Dhananjay Yadav

Department of Life Science,, Yeungnam University

编辑信件的主要联系方式.
Email: info@benthamscience.net

Santosh Singh

Department of Biotechnology, Arka Jain University

Email: info@benthamscience.net

Sung Kim

Department of Pharmacology, College of Medicine, University of Ulsan

Email: info@benthamscience.net

Shivendra Singh

Department of Basic Sciences, Amity School of Engineering and Technology (ASET),, Amity University

Email: info@benthamscience.net

Shweta Katiyar

Department of Botany, SBN Government PG College

Email: info@benthamscience.net

Minseok Song

Department of Life Science, Yeungnam University

Email: info@benthamscience.net

参考

  1. Zhang X. WHO Traditional Medicine Strategy 2002-2005. 2002. Available from: https://www.iso.org/standard/70958.html
  2. Darokar MP, Khanuja SPS, Kumar Shasany A, Kumar S. Low levels of genetic diversity detected by RAPD analysis in geographically distinct accessions of Bacopa monnieri. Genet Resour Crop Evol 2001; 48(6): 555-8. doi: 10.1023/A:1013800101604
  3. Joshi H, Parle M. Brahmi rasayana improves learning and memory in mice. Evid Based Complement Alternat Med 2006; 3(1): 79-85. doi: 10.1093/ecam/nek014 PMID: 16550227
  4. Singh H, Raghav S, Dalal PK, Srivastava JS, Asthana OP. Randomized controlled trial of standardized Bacopa monniera extract in age-associated memory impairment. Indian J Psychiatry 2006; 48(4): 238-42. doi: 10.4103/0019-5545.31555 PMID: 20703343
  5. Phrompittayarat W, Putalun W, Tanaka H, Jetiyanon K, Wittaya-Areekul S, Ingkaninan K. Comparison of various extraction methods of Bacopa monnieri. NUJST 2013; 15: 29-34.
  6. Bhattacharya SK, Bhattacharya A, Kumar A, Ghosal S. Antioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampus. Phytother Res 2000; 14(3): 174-9. doi: 10.1002/(SICI)1099-1573(200005)14:33.0.CO;2-O PMID: 10815010
  7. Jyoti A, Sharma D. Neuroprotective role of Bacopa monniera extract against aluminium-induced oxidative stress in the hippocampus of rat brain. Neurotoxicology 2006; 27(4): 451-7. doi: 10.1016/j.neuro.2005.12.007 PMID: 16500707
  8. Russo A, Borrelli F. Bacopa monniera, a reputed nootropic plant: an overview. Phytomedicine 2005; 12(4): 305-17. doi: 10.1016/j.phymed.2003.12.008 PMID: 15898709
  9. Murthy PBS, Raju VR, Ramakrisana T, et al. Estimation of twelve bacopa saponins in Bacopa monnieri extracts and formulations by high-performance liquid chromatography. Chem Pharm Bull 2006; 54(6): 907-11. doi: 10.1248/cpb.54.907 PMID: 16755069
  10. Gudipati T, Srivastava P, Bhadauria R, Prasad G. Hepatoprotective potential of in vitro Bacopa monnieri (L.) against carbon tetrachloride-induced hepatotoxicity in albino mice. Int J Pharm Biol Sci 2012; 3: 664-72.
  11. Gudipati T, Srivastava P, Goswami H, Bhadauria R. In vitro conservation of Bacopa monnieri germplasm: A critically endangered medicinal plant of madhya pradesh. J Indian Bot Soc 2012; 91: 83-91.
  12. Negi K, Singh Y, Kushwaha K, et al. Clinical evaluation of memory enhancing properties of memory plus in children with attention deficit hyperactivity disorder. Indian J Psychiatry 2000; 42(4)
  13. Biharee A, Chaudhari L, Bhartiya S, et al. A comprehensive study on natural products and their bioactive constituents to cure respiratory diseases. Nat Prod J 2024; 14(2): e120623217879. doi: 10.2174/2210315513666230612111133
  14. Trupti P, Aditi C, Kajal K, Nameerah R, Rakhe N, Shaikh KA. Ayurvedic remedies of tuberculosis. World J Adv Res Rev 2021; 11(3): 280-90. doi: 10.30574/wjarr.2021.11.3.0466
  15. Makhaik M S, Shakya A K, Kale R. Dietary phytochemicals: As a natural source of antioxidants. In: Antioxidants - Benefits, Sources, Mechanisms of Action IntechOpen. 2021.
  16. Husain A, Kaushik A, Awasthi H, Singh DP, Khan R, Mani D. Immunomodulatory and antioxidant activities of fresh juice extracts of Brahmi and Guduchi. Indian J Tradit Knowl 2017; 16: 498-505.
  17. Bairy K. Wound healing potentials of plant products. J Nat Rem 2002; 2: 11-20.
  18. Mondal S, Bhar K, Mondal P, et al. In quest of the mysterious holistic vedic herb Bacopa monnieri (L.) Pennell. Pharmacognosy Res 2023; 15(3): 410-54. doi: 10.5530/pres.15.3.045
  19. Ramadas D, Ravishankar M, Shwetha S, Chikkanna D. Phytochemical studies and antioxidant activity of Bacopa monnieri plant leaves proteins. Indo Am J Pharm Res 2016; 6: 4302-7.
  20. Sivaramakrishna C, Rao CV, Trimurtulu G, Vanisree M, Subbaraju GV. Triterpenoid glycosides from Bacopa monnieri. Phytochemistry 2005; 66(23): 2719-28. doi: 10.1016/j.phytochem.2005.09.016 PMID: 16293276
  21. Bhandari P, Kumar N, Singh B, Kaul VK. Bacosterol glycoside, a new 13,14-seco-steroid glycoside from Bacopa monnieri. Chem Pharm Bull 2006; 54(2): 240-1. doi: 10.1248/cpb.54.240 PMID: 16462073
  22. Jeyasri R, Muthuramalingam P, Suba V, Ramesh M, Chen JT. Bacopa monnieri and their bioactive compounds inferred multi-target treatment strategy for neurological diseases: A cheminformatics and system pharmacology approach. Biomolecules 2020; 10(4): 536. doi: 10.3390/biom10040536 PMID: 32252235
  23. Jeyasri R, Muthuramalingam P, Adarshan S, Shin H, Ramesh M. Assessing the anti-inflammatory effects of bacopa-derived bioactive compounds using network pharmacology and in vitro studies. ACS Omega 2022; 7(44): 40344-54. doi: 10.1021/acsomega.2c05318 PMID: 36385888
  24. Yaribeygi H, Panahi Y, Javadi B, Sahebkar A. The underlying role of oxidative stress in neurodegeneration: A mechanistic review. CNS Neurol Disord Drug Targets 2018; 17: 207-15.
  25. Rehman MU, Sehar N, Dar NJ, et al. Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: An update on current advances and impediments. Neurosci Biobehav Rev 2023; 144: 104961. doi: 10.1016/j.neubiorev.2022.104961 PMID: 36395982
  26. Hague SM, Klaffke S, Bandmann O. Neurodegenerative disorders: Parkinson’s disease and Huntington’s disease. J Neurol Neurosurg Psychiatry 2005; 76(8): 1058-63. doi: 10.1136/jnnp.2004.060186 PMID: 16024878
  27. Trojanowski JQ, Lee VM. "Fatal attractions" of proteins. A comprehensive hypothetical mechanism underlying Alzheimer’s disease and other neurodegenerative disorders. Ann N Y Acad Sci 2000; 924(1): 62-7. doi: 10.1111/j.1749-6632.2000.tb05561.x PMID: 11193803
  28. Jennekens FGI. A short history of the notion of neurodegenerative disease. J Hist Neurosci 2014; 23(1): 85-94. doi: 10.1080/0964704X.2013.809297 PMID: 24512132
  29. Radunovic A, Annane D, Rafiq MK, Brassington R, Mustfa N. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Libr 2017; 2018(6): CD004427. doi: 10.1002/14651858.CD004427.pub4 PMID: 28982219
  30. Sharifi-Rad M, Lankatillake C, Dias DA, et al. Impact of natural compounds on neurodegenerative disorders: From preclinical to pharmacotherapeutics. J Clin Med 2020; 9(4): 1061. doi: 10.3390/jcm9041061 PMID: 32276438
  31. Hussain G, Rasul A, Anwar H, et al. Role of plant derived alkaloids and their mechanism in neurodegenerative disorders. Int J Biol Sci 2018; 14(3): 341-57. doi: 10.7150/ijbs.23247 PMID: 29559851
  32. Singh K, Yadav D, Chauhan PS, Mishra M, Jin JO. Novel therapeutics for the treatment of Alzheimer’s and Parkinson’s disease. Curr Pharm Des 2020; 26(7): 755-63. doi: 10.2174/1381612826666200107161051 PMID: 31914906
  33. Chauhan P S, Yadav D, Arukha A P. Dietary nutrients and prevention of Alzheimer’s disease. CNS Neurol Disord Drug Targets 2022; 21: 217-27.
  34. Koul B, Farooq U, Yadav D, Song M. Phytochemicals: A promising alternative for the prevention of Alzheimer’s disease. Life 2023; 13(4): 999. doi: 10.3390/life13040999 PMID: 37109528
  35. Chauhan PS, Yadav D, Koul B, Mohanta YK, Jin JO. Recent advances in nanotechnology: A novel therapeutic system for the treatment of Alzheimer’s disease. Curr Drug Metab 2020; 21(14): 1144-51. doi: 10.2174/1389200221666201124140518 PMID: 33234100
  36. Shankar PS, Preeti B, Santanu B, Gajanan D, Rupesh D. Brahmi (Bacopa monnieri) as functional food ingredient in food processing industry. J Pharmacogn Phytochem 2018; 7: 189-94.
  37. Otari SS, Devkar SP, Patel SB, Ghane SG. Micropropagation and elicited production of triterpenoid saponin glycosides and stigmasterol via precursor and elicitor feeding in Bacopa floribunda (R.Br.) Wettst-A potential nootropic herb. Front Plant Sci 2023; 14: 1096842. doi: 10.3389/fpls.2023.1096842 PMID: 36798714
  38. Fatima U, Roy S, Ahmad S, et al. Pharmacological attributes of Bacopa monnieri extract: Current updates and clinical manifestation. Front Nutr 2022; 9: 972379. doi: 10.3389/fnut.2022.972379 PMID: 36061899
  39. Kumari A, Kumar A, Mandal S, Roy P, Sircar D. A metabolic reprogramming in Bacopa monnieri plants induced by methyl-jasmonate and enhanced biosynthesis of triterpene saponins. Ind Crops Prod 2023; 204: 117241. doi: 10.1016/j.indcrop.2023.117241
  40. Saesong T, Allard P-M, Queiroz EF, et al. Discovery of lipid peroxidation inhibitors from Bacopa species prioritized through multivariate data analysis and multi-informative molecular networking. Molecules 2019; 24(16): 2989. doi: 10.3390/molecules24162989 PMID: 31426532
  41. Giramkar SA, Kulkarni OP, Jagtap SD, et al. Anticonvulsant potential of commonly practiced formulations of Brahmi (Bacopa monnieri Linn.) in Wistar rats. J Pharm Res 2013; 7(9): 787-91. doi: 10.1016/j.jopr.2013.09.008
  42. Khan MB, Ahmad M, Ahmad S, et al. Bacopa monniera ameliorates cognitive impairment and neurodegeneration induced by intracerebroventricular-streptozotocin in rat: behavioral, biochemical, immunohistochemical and histopathological evidences. Metab Brain Dis 2015; 30(1): 115-27. doi: 10.1007/s11011-014-9593-5 PMID: 25037167
  43. Dhanasekaran M, Tharakan B, Holcomb LA, Hitt AR, Young KA, Manyam BV. Neuroprotective mechanisms of ayurvedic antidementia botanical Bacopa monniera. Phytother Res 2007; 21(10): 965-9. doi: 10.1002/ptr.2195 PMID: 17604373
  44. Mathew J, Balakrishnan S, Antony S, Abraham PM, Paulose CS. Decreased GABA receptor in the cerebral cortex of epileptic rats: effect of Bacopa monnieri and Bacoside-A. J Biomed Sci 2012; 19(1): 25. doi: 10.1186/1423-0127-19-25 PMID: 22364254
  45. Hasler G. Pathophysiology of depression: Do we have any solid evidence of interest to clinicians? World Psychiatry 2010; 9(3): 155-61. doi: 10.1002/j.2051-5545.2010.tb00298.x PMID: 20975857
  46. Craft LL, Perna FM. The benefits of exercise for the clinically depressed. Prim Care Companion J Clin Psychiatry 2004; 6(3): 104-11. PMID: 15361924
  47. Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MA. The serotonin theory of depression: A systematic umbrella review of the evidence. Mol Psychiatry 2023; 28(8): 3243-56. doi: 10.1038/s41380-022-01661-0 PMID: 35854107
  48. Sairam K, Dorababu M, Goel RK, Bhattacharya SK. Antidepressant activity of standardized extract of Bacopa monniera in experimental models of depression in rats. Phytomedicine 2002; 9(3): 207-11. doi: 10.1078/0944-7113-00116 PMID: 12046860
  49. Hazra S, Banerjee R, Das BK, et al. Evaluation of antidepressant activity of Bacopa monnieri in rat: A study in animal model of depression. Drug Discov 2012; 2: 8-13.
  50. Rai D, Bhatia G, Palit G, Pal R, Singh S, Singh HK. Adaptogenic effect of Bacopa monniera (Brahmi). Pharmacol Biochem Behav 2003; 75(4): 823-30. doi: 10.1016/S0091-3057(03)00156-4 PMID: 12957224
  51. Shahid M, Subhan F, Ullah I, Ali G, Alam J, Shah R. Beneficial effects of Bacopa monnieri extract on opioid induced toxicity. Heliyon 2016; 2(2): e00068. doi: 10.1016/j.heliyon.2016.e00068 PMID: 27441247
  52. Akram M, Nawaz A. Effects of medicinal plants on Alzheimer’s disease and memory deficits. Neural Regen Res 2017; 12(4): 660-70. doi: 10.4103/1673-5374.205108 PMID: 28553349
  53. Gold CA, Budson AE. Memory loss in Alzheimer’s disease: Implications for development of therapeutics. Expert Rev Neurother 2008; 8(12): 1879-91. doi: 10.1586/14737175.8.12.1879 PMID: 19086882
  54. Singhal A, Bangar OP, Naithani V. Medicinal plants with a potential to treat Alzheimer and associated symptoms. Int J Nutr Pharmacol Neurol Dis 2012; 2(2): 84-91. doi: 10.4103/2231-0738.95927
  55. Glabe C. Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer’s disease. J Mol Neurosci 2001; 17(2): 137-45. doi: 10.1385/JMN:17:2:137 PMID: 11816787
  56. Takahashi RH, Nagao T, Gouras GK. Plaque formation and the intraneuronal accumulation of β‐amyloid in Alzheimer’s disease. Pathol Int 2017; 67(4): 185-93. doi: 10.1111/pin.12520 PMID: 28261941
  57. Liguori I, Russo G, Curcio F, et al. Oxidative stress, aging, and diseases. Clin Interv Aging 2018; 13: 757-72. doi: 10.2147/CIA.S158513 PMID: 29731617
  58. Malishev R, Shaham-Niv S, Nandi S, Kolusheva S, Gazit E, Jelinek R. Bacoside-A, an Indian traditional-medicine substance, inhibits β-amyloid cytotoxicity, fibrillation, and membrane interactions. ACS Chem Neurosci 2017; 8(4): 884-91. doi: 10.1021/acschemneuro.6b00438 PMID: 28094495
  59. Golde TE, Schneider LS, Koo EH. Anti-aβ therapeutics in Alzheimer’s disease: The need for a paradigm shift. Neuron 2011; 69(2): 203-13. doi: 10.1016/j.neuron.2011.01.002 PMID: 21262461
  60. Abdul Manap AS, Vijayabalan S, Madhavan P, et al. Bacopa monnieri, a neuroprotective lead in Alzheimer disease: A review on its properties, mechanisms of action, and preclinical and clinical studies. Drug Target Insights 2019; 13: 1177392819866412. doi: 10.1177/1177392819866412 PMID: 31391778
  61. Wiatrak B, Jawień P, Matuszewska A, Szeląg A, Kubis-Kubiak A. Effect of amyloid-β on the redox system activity in SH-SY5Y cells preincubated with lipopolysaccharide or co-cultured with microglia cells. Biomed Pharmacother 2022; 149: 112880. doi: 10.1016/j.biopha.2022.112880 PMID: 35367762
  62. Goswami S, Saoji A, Kumar N, Thawani V, Tiwari M, Thawani M. Effect of Bacopa monnieri on cognitive functions in Alzheimer’s disease patients. Int J Collaborat Res Int Med Public Health 2011; 3: 285-93.
  63. Kunte KB, Kuna Y. Neuroprotective effect of Bacopa monniera on memory deficits and ATPase system in Alzheimer’s disease (AD) induced mice. J Sci Innov Res 2013; 2: 719-35.
  64. Uabundit N, Wattanathorn J, Mucimapura S, Ingkaninan K. Cognitive enhancement and neuroprotective effects of Bacopa monnieri in Alzheimer’s disease model. J Ethnopharmacol 2010; 127(1): 26-31. doi: 10.1016/j.jep.2009.09.056 PMID: 19808086
  65. Morgan A, Stevens J. Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial. J Altern Complement Med 2010; 16(7): 753-9. doi: 10.1089/acm.2009.0342 PMID: 20590480
  66. McPhee GM, Downey LA, Wesnes KA, Stough C. The neurocognitive effects of Bacopa monnieri and cognitive training on markers of brain microstructure in healthy older adults. Front Aging Neurosci 2021; 13: 638109. doi: 10.3389/fnagi.2021.638109 PMID: 33692683

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bentham Science Publishers, 2024